Anhui Baker Biopharmaceutical

Anhui Baker Biopharmaceutical (also known as Anhui Biochem Pharmaceutical) is a leading Chinese high-tech pharmaceutical company specializing in the research, development, and large-scale manufacturing of antiviral medications, particularly for HIV/AIDS and Hepatitis B. Founded in 2007 and headquartered in Taihe County, Anhui, the company has established a vertically integrated industrial chain from active pharmaceutical ingredients (APIs) to finished dosage forms. It is a primary supplier for China's national free antiretroviral treatment program and exports its products to international markets across Africa and Southeast Asia. The company is recognized for its expertise in chiral drug synthesis and has expanded its portfolio to include treatments for tuberculosis, Parkinson's disease, and inflammatory conditions. Additionally, it provides CDMO services for small molecules and has been instrumental in reducing China's reliance on imported antiviral therapies.